Breaking the Seizure Cycle: Surgical Outcomes of Medial Temporal Lobectomy in Drug-Resistant Epilepsy

A medial temporal lobectomy, alone or in combination with amygdalohippocampectomy, serves as an effective surgical treatment for drug-resistant TLE. Most patients experience both a reduction in seizure frequency and severity while seizure freedom occurs in the majority after the procedure. These results support surgical management as an essential treatment option for medically refractory epilepsy and highlight the importance of identifying patients for early surgical evaluation. More studies with bigger sample sizes along with extended follow-up periods should be performed to improve patient selection criteria and surgical methods that enhance patient outcomes.